UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

__________________

 

FORM 6-K   

__________________

 

Report of Foreign Private Issuer

  Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

 

For the month of February, 2017

 

Commission File Number: 001-36619

 __________________________________

 

Affimed N.V.

__________________________________

 

Im Neuenheimer Feld 582,

  69120 Heidelberg,

Germany

(Address of principal executive offices) 

__________________________________

 


Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒          Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

 

 

 

On February 8, 2017, Affimed N.V. (“Affimed” or the “Company”) issued and sold 646,762 of its common shares pursuant to the partial exercise of the underwriters’ 30-day option to purchase additional common shares (the “Option Exercise”) in connection with the Company’s public offering of its common shares, which closed on January 25, 2017. The net proceeds to the Company from the Option Exercise are expected to be approximately $1.1 million, after deducting underwriting discounts.

 

The offering was made pursuant to Affimed’s effective registration statement on Form F-3 (Registration Statement No. 333-207235) previously filed with the Securities and Exchange Commission and a prospectus supplement thereunder.

 

A copy of the opinion of De Brauw Blackstone Westbroek N.V. relating to the validity of the common shares issued and sold pursuant to the Option Exercise is attached as Exhibit 5.1 hereto.

 

 

INCORPORATION BY REFERENCE

 

This Report on Form 6-K shall be deemed to be incorporated by reference into the registration statements on Form F-3 (Registration Number 333-207235) and Form S-8 (Registration Number 333-198812) of Affimed N.V. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in Heidelberg, Germany, February 8, 2017.

 

 

AFFIMED N.V.

 

  By: /s/ Adi Hoess
    Name: Adi Hoess
    Title: Chief Executive Officer
       
       
  By: /s/ Florian Fischer
    Name: Florian Fischer
    Title: Chief Financial Officer

 

 

 

EXHIBIT INDEX

 

Exhibit Description of Exhibit
5.1 Opinion of De Brauw Blackstone Westbroek N.V.
23.1 Consent of De Brauw Blackstone Westbroek N.V. (included in Exhibit 5.1)

 

 

 

Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Affimed NV Charts.
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Affimed NV Charts.